Phase III Study of FFI-1010 in Pediatric Kidney Disease
Condition: Children Under 18 Years Old With Kidney Disease Intervention: Drug: FFI-1010 Sponsor: Fuji Yakuhin Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials